Pages that link to "Q46570726"
Jump to navigation
Jump to search
The following pages link to Low-dose thalidomide in myelofibrosis (Q46570726):
Displaying 15 items.
- Thalidomide treatment in a myelofibrosis patient with leukemia transformation (Q33411894) (← links)
- Profile of pomalidomide and its potential in the treatment of myelofibrosis (Q35427915) (← links)
- Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet. (Q37163590) (← links)
- Novel strategies for patients with chronic myeloproliferative disorders. (Q37495389) (← links)
- Palliative oncology: thalidomide (Q37618475) (← links)
- Therapeutic approaches in myelofibrosis. (Q37860336) (← links)
- Treatment and management of myelofibrosis in the era of JAK inhibitors (Q38132739) (← links)
- Immunotherapy based approaches in myelofibrosis (Q38629189) (← links)
- Primary myelofibrosis: current therapeutic options (Q41186952) (← links)
- Human Immunodeficiency Virus Related Myelofibrosis Responsive to Low Dose Thalidomide (Q45336324) (← links)
- Two cases of myelofibrosis with severe thrombocytopenia and symptomatology successfully treated with combination of pomalidomide and ruxolitinib (Q48074196) (← links)
- SOHO State-of-the-Art Update and Next Questions: MPN. (Q49580473) (← links)
- The stromal composition of mast cell aggregates in systemic mastocytosis (Q83734931) (← links)
- Management of Myelofibrosis-Related Cytopenias (Q88800685) (← links)
- Guideline on myeloproliferative neoplasms: Associacão Brasileira de Hematologia, Hemoterapia e Terapia Cellular: Project guidelines: Associação Médica Brasileira - 2019 (Q93085740) (← links)